Skip to main content
Figure 7 | Molecular Cancer

Figure 7

From: Effects of HDM2 antagonism on sunitinib resistance, p53 activation, SDF-1 induction, and tumor infiltration by CD11b+/Gr-1+ myeloid derived suppressor cells

Figure 7

The effects of treatment on α(II) PH, endostatin, and arresten levels in RCC xenografts. A, B). The expression of all three proteins was induced by sunitinib treatment and levels did not diminish with the onset of drug resistance. C, D). Levels of endostatin and arresten were increased by treatment with either sunitinib or MI-319 but the inductive effects of the two drugs were not additive. Lanes represent data from individual tumors for each treatment group.

Back to article page